Scope of the License. 3.1.1 ▇▇▇▇ accepts that the CMO appointed in accordance with this Addendum is entitled to use the API Technology and API Specifications in order to manufacture API for Serendex. 3.1.2 ▇▇▇▇ shall transfer the Technology Assets listed in Appendix 3 to the CMO and any other API Technology required in order to enable the CMO to manufacture API for Serendex. 3.1.3 ▇▇▇▇ shall provide sufficient information in order to enable the CMO to produce the API in accordance with the API Specifications and in accordance with the Quality Agreement. 3.1.4 Any API Technology, including but not limited to the Technology Assets, transferred to the CMO, shall remain the ownership of ▇▇▇▇ until the total purchase price for acquiring the MCB and WCB form ▇▇▇▇, has been executed by Serendex. 3.1.5 The CMO is solely entitled to use the API Technology and API Specifications in accordance with the License and for the purpose of manufacture API (i) to be supplied to Serendex or (ii) to be used in the production of Finished Products for Serendex. 3.1.6 The terms and conditions of the CMO’s manufacture and supply of API and/or Finished Products to Serendex is regulated by separate agreement between Serendex and the CMO. [***] Indicates that information has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
Appears in 2 contracts
Sources: Supply and License Agreement (Mast Therapeutics, Inc.), Supply and License Agreement (Mast Therapeutics, Inc.)